Bulgaria
· Delayed Price · Currency is BGN Sopharma Trading AD Statistics
Total Valuation
Sopharma Trading AD has a market cap or net worth of BGN 200.51 million. The enterprise value is 459.68 million.
| Market Cap | 200.51M |
| Enterprise Value | 459.68M |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sopharma Trading AD has 34.28 million shares outstanding. The number of shares has increased by 0.65% in one year.
| Shares Outstanding | 34.28M |
| Shares Change (YoY) | +0.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 1.26% |
| Float | 4.36M |
Valuation Ratios
The trailing PE ratio is 5.79.
| PE Ratio | 5.79 |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| PB Ratio | 1.36 |
| P/FCF Ratio | 6.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.42, with an EV/FCF ratio of 14.62.
| EV / Earnings | 13.24 |
| EV / Sales | 0.26 |
| EV / EBITDA | 5.42 |
| EV / EBIT | 9.34 |
| EV / FCF | 14.62 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 183.66.
| Current Ratio | 1.10 |
| Quick Ratio | 0.60 |
| Debt / Equity | 183.66 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | 8.60 |
| Interest Coverage | 5.35 |
Financial Efficiency
Return on equity (ROE) is 26.59% and return on invested capital (ROIC) is 7.76%.
| Return on Equity (ROE) | 26.59% |
| Return on Assets (ROA) | 4.61% |
| Return on Capital (ROIC) | 7.76% |
| Revenue Per Employee | 638,431 |
| Profits Per Employee | 12,521 |
| Employee Count | 2,616 |
| Asset Turnover | 2.66 |
| Inventory Turnover | 6.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.65% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.65% |
| 50-Day Moving Average | 5.82 |
| 200-Day Moving Average | 5.91 |
| Relative Strength Index (RSI) | 54.04 |
| Average Volume (20 Days) | 3,749 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sopharma Trading AD had revenue of BGN 1.77 billion and earned 34.72 million in profits. Earnings per share was 1.01.
| Revenue | 1.77B |
| Gross Profit | 213.69M |
| Operating Income | 49.19M |
| Pretax Income | 38.03M |
| Net Income | 34.72M |
| EBITDA | 68.23M |
| EBIT | 49.19M |
| Earnings Per Share (EPS) | 1.01 |
Balance Sheet
The company has 11.21 million in cash and 270.37 million in debt, giving a net cash position of -259.16 million or -7.56 per share.
| Cash & Cash Equivalents | 11.21M |
| Total Debt | 270.37M |
| Net Cash | -259.16M |
| Net Cash Per Share | -7.56 |
| Equity (Book Value) | 147.21M |
| Book Value Per Share | 4.29 |
| Working Capital | 50.97M |
Cash Flow
In the last 12 months, operating cash flow was 44.19 million and capital expenditures -12.74 million, giving a free cash flow of 31.45 million.
| Operating Cash Flow | 44.19M |
| Capital Expenditures | -12.74M |
| Free Cash Flow | 31.45M |
| FCF Per Share | 0.92 |
Margins
Gross margin is 12.07%, with operating and profit margins of 2.78% and 1.96%.
| Gross Margin | 12.07% |
| Operating Margin | 2.78% |
| Pretax Margin | 2.15% |
| Profit Margin | 1.96% |
| EBITDA Margin | 3.85% |
| EBIT Margin | 2.78% |
| FCF Margin | 1.78% |
Dividends & Yields
Sopharma Trading AD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.65% |
| Shareholder Yield | -0.65% |
| Earnings Yield | 17.26% |
| FCF Yield | 15.69% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sopharma Trading AD has an Altman Z-Score of 3.22.
| Altman Z-Score | 3.22 |
| Piotroski F-Score | n/a |